Voxxil Technologies

Meeting with the then US Ambassador to Guyana

Company Partnerships Investors
Co-founder Andrew Garnett with then US Ambassador Sarah-Ann Lynch.
Co-founder Andrew Garnett with then US Ambassador Sarah-Ann Lynch.

We have had conversations with investors who wanted to understand the medical software market in the Caribbean, with regional partners shaping the country’s future, and with stakeholders whose work touches healthcare in ways that complement what we are building.

Talking to investors

Across several meetings in Georgetown and online, we walked through the platform: Voxxil-HIS, the four products inside it, the AI quality validation work being piloted with physicians across the region, and where we see medical software heading over the next five years. Investors familiar with healthcare in emerging markets asked sharp questions about training data, regulatory pathways, partner facility traction, and unit economics. We came away with a clearer view of what the next stage looks like for the company and a better way of telling that story.

Connecting with the people shaping the region

Healthcare software is not built in isolation. It depends on the wider environment around it: connectivity, regulation, education, and partners who can move resources to where they are most needed. A few conversations in particular stood out.

The US Ambassador to Guyana. We had the chance to introduce Voxxil at an event in Georgetown and to speak briefly about the work being done locally on medical AI and clinical software. Her interest in what is being built in-country, and by whom, was encouraging. Voxxil’s founders are Guyanese, our infrastructure runs on data contributed by hospitals here, and the people we are designing for are our neighbours. That story landed well.

The Regional Representative for USAID. USAID’s health systems strengthening work across the Caribbean overlaps directly with the gap Voxxil exists to close. We spoke about where their regional programs and the kind of platform Voxxil is building might naturally fit together, particularly around imaging and laboratory infrastructure for facilities that have been historically underserved.

The CEO of GTT. GTT’s leadership was among Voxxil’s earliest backers, investing in the company through Guyana’s Economic Development Fund. That kind of belief, from someone who understands both the country’s digital infrastructure and the importance of growing local technology companies, has meant a great deal to us as we have grown.

Where this leaves us

We have always said Voxxil is a Caribbean-first company, building the software that facilities in this region actually need. These conversations reinforced that conviction. There is real momentum in Guyana right now, and we met lots of people doing the quiet work of making sure the country’s growth translates into better outcomes for ordinary patients. We are glad to be playing a small part in that, and we are keeping our heads down and shipping.

If you are an investor, a clinician, or a partner organization who would like to talk, we are easy to reach.